Payers for health care are pursuing a variety of policies as part of broader efforts to improve the quality and efficiency of care. Payment reform is but one policy tool to improve health system performance that requires supportive measures in place such as policies with well-developed stakeholder involvement, information on quality, clear criteria for tariff setting, and embedding evaluation as part of the policy process. Countries should not, however, underestimate the significant data challenges when looking at price setting processes. Data access and ways to overcome its fragmentation require well-developed infrastructures. Policy efforts highlight a trend towards aligning payer and provider incentives by using evidence-based clinical guidelines and outcomes to inform price setting. There are signs of increasing policy focus on outcomes to inform price setting. These efforts could bring about system-wide effects of using evidence along with a patient-centred focus to improve health care delivery and performance in the long-run.
The objective of the HCQI Project is to develop a set of indicators based on comparable data and which can be used to raise questions for further investigation on quality differences across countries.
This new OECD series aims to highlight the latest data in selected countries, to explain their health care systems and to provide key information in a clear and concise way. Each country snapshot highlights the most pertinent issues, be it smoking, obesity, surgical interventions, consumption of antibiotics, physicians density, etc., with the help of key statistics and are followed by brief policy recommendations.
La base de données Statistiques de l'OCDE sur la santé 2015 représente la source statistique la plus vaste pour comparer les systèmes de santé des pays de l'OCDE.
The OECD Health Division is releasing a new series to highlight its work on health policies and data. A new graph will be available each month.
At the OECD, we have calculated that about 50% of all the antimicrobials prescribed by healthcare facilities in our member countries do not meet prescription guidelines. In healthcare services such as long-term care facilities and general practices up to 70% and 90% respectively of antibiotics may be prescribed for inappropriate reasons.
This report provides a comprehensive assessment of the economic consequences of outdoor air pollution in the coming decades, focusing on the impacts on mortality, morbidity, and changes in crop yields as caused by high concentrations of pollutants. Unless more stringent policies are adopted, findings point to a significant increase in global emissions and concentrations of air pollutants, with severe impacts on human health and the environment. The market impacts of outdoor air pollution are projected to lead to significant economic costs, which are illustrated at the regional and sectoral levels, and to substantial annual global welfare costs.
Si nous n’agissons pas, la pollution de l’air extérieur pourrait entraîner 6 à 9 millions de décès prématurés d’ici 2060 et coûter 1 % du PIB mondial – soit quelque 2 600 milliards USD par an – du fait des jours de congé de maladie, des frais médicaux et de la réduction de la production agricole, selon un nouveau rapport de l’OCDE.
Universal Health Coverage is about everyone having access to good quality health services without suffering financial hardship. Although most OECD countries offer all their citizens affordable access to a comprehensive package of health services, they face challenges in sustaining and enhancing such universal systems.
The OECD Health Working Papers series is designed to make available to a wider readership health studies prepared for use within the OECD.